牧原股份
Search documents
牧原股份:第三季度归母净利润42.49亿元,同比下降55.98%
Xin Lang Cai Jing· 2025-10-30 11:50
Core Viewpoint - The company reported a decline in revenue and net profit for Q3 2025, while showing growth in the first three quarters of the year compared to the same period last year [1] Group 1: Q3 Performance - In Q3 2025, the company achieved revenue of 35.327 billion yuan, a year-on-year decrease of 11.48% [1] - The net profit attributable to shareholders was 4.249 billion yuan, down 55.98% year-on-year [1] - Basic earnings per share for Q3 were 0.78 yuan [1] Group 2: Year-to-Date Performance - For the first three quarters of 2025, the company reported revenue of 111.79 billion yuan, an increase of 15.52% year-on-year [1] - The net profit attributable to shareholders for the first three quarters was 14.779 billion yuan, reflecting a year-on-year growth of 41.01% [1] - Basic earnings per share for the first three quarters were 2.74 yuan [1]
牧原股份:第三季度净利润42.49亿元 同比下降55.98%
Zheng Quan Shi Bao Wang· 2025-10-30 11:47
Core Viewpoint - Muyuan Foods (002714) reported a decline in third-quarter revenue and net profit, indicating potential challenges in the current market environment [1] Financial Performance Summary - In Q3, the company achieved a revenue of 35.327 billion yuan, a year-on-year decrease of 11.48% [1] - The net profit for Q3 was 4.249 billion yuan, reflecting a significant year-on-year decline of 55.98% [1] - For the first three quarters, the total revenue reached 111.79 billion yuan, showing a year-on-year growth of 15.52% [1] - The net profit for the first three quarters was 14.779 billion yuan, which represents a year-on-year increase of 41.01% [1]
牧原股份(002714) - 2025 Q3 - 季度财报
2025-10-30 11:40
Revenue and Profitability - Revenue for Q3 2025 was CNY 35.33 billion, a decrease of 11.48% year-over-year[6] - Net profit attributable to shareholders was CNY 4.25 billion, down 55.98% compared to the same period last year[6] - Basic earnings per share decreased by 56.42% to CNY 0.78[6] - Total operating revenue for the current period reached ¥111.79 billion, a 15.5% increase from ¥96.78 billion in the previous period[20] - Net profit for the current period was ¥15.11 billion, representing a 34.5% increase compared to ¥11.25 billion in the previous period[21] - Basic earnings per share rose to ¥2.74, up from ¥1.94 in the previous period, reflecting a 41.3% increase[21] Assets and Liabilities - Total assets at the end of the reporting period were CNY 180.76 billion, a decrease of 3.67% from the end of the previous year[6] - As of September 30, 2025, the total assets amount to RMB 180.76 billion, a decrease from RMB 187.65 billion at the beginning of the period, reflecting a reduction of approximately 3.8%[18][19] - The total current liabilities decreased from RMB 85.48 billion to RMB 76.80 billion, representing a decline of about 10.5%[19] - The total liabilities decreased from RMB 110.11 billion to RMB 100.32 billion, indicating a reduction of approximately 8.0%[19] - The company reported a significant increase in other payables, rising from RMB 8.35 billion to RMB 11.84 billion, an increase of approximately 42.5%[19] Cash Flow - The company reported a net cash flow from operating activities of CNY 28.58 billion, a decrease of 2.05% year-to-date[6] - Cash flow from operating activities generated ¥28.58 billion, slightly down from ¥29.18 billion in the previous period[23] - Cash inflow from investment activities was ¥8.58 billion, compared to ¥7.10 billion in the previous period, marking a 20.8% increase[24] - Cash outflow from investment activities totaled ¥17.08 billion, down from ¥19.77 billion year-over-year[24] - The net cash outflow from financing activities was -15,656,261,351.92, compared to -14,540,648,643.14 in the previous period, indicating a worsening trend[25] - The total cash and cash equivalents at the end of the period increased to 17,268,736,105.83 from 15,745,131,519.77, reflecting a net increase of 4,424,184,492.75[25] Equity and Share Repurchase - The total equity attributable to shareholders increased by 6.72% to CNY 76.87 billion compared to the end of the previous year[6] - The total equity attributable to the parent company increased from RMB 72.03 billion to RMB 76.87 billion, reflecting an increase of approximately 6.0%[19] - The total amount for the share repurchase plan announced on September 27, 2024, is between RMB 30 billion and RMB 40 billion, with a target to repurchase approximately 69.59 million shares from October 18, 2024, to August 26, 2025[16] - The company repurchased a total of 41.87 million shares in the previous buyback program, which was completed by September 2025[15] Investments and Future Plans - Investment income increased by 127.15% year-over-year, primarily due to increased returns from joint ventures[12] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[20] Accounting and Reporting - The third quarter financial report was not audited, which may affect the reliability of the reported figures[26] - The company will implement new accounting standards starting in 2025, which may impact future financial reporting[27]
牧原股份(002714) - 关于对外捐赠的公告
2025-10-30 11:39
| 证券代码:002714 | 证券简称:牧原股份 | 公告编号:2025-101 | | --- | --- | --- | | 债券代码:127045 | 债券简称:牧原转债 | | 牧原食品股份有限公司 关于对外捐赠的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有 虚假记载、误导性陈述或重大遗漏。 一、捐赠事项概述 为践行牧原食品股份有限公司(以下简称"公司")"创造价值,服务社会"的 核心价值观,积极履行社会责任,资助公益教育、科研事业的建设及发展,公司 已自愿向杭州市西湖教育基金会捐赠人民币 1 亿元。其中 6,000 万元留于杭州市 西湖教育基金会用于资助西湖大学人才建设、学科建设、基础建设、学生培养、 学术交流、科研与其他人员薪酬奖励补助以及与动物营养、智慧农业、生命健康、 畜牧生产与智慧兽医等相关研究领域的发展;4,000 万元用于资助西湖大学参与 支持共建的南阳市西湖牧原合成生物研究院的建设及发展。 二、捐赠对象基本情况 组织名称:杭州市西湖教育基金会 法定代表人:秦英林 统一社会信用代码:53330100336424472F 住所:浙江省杭州市西湖区三墩镇墩余路600 ...
养殖业板块10月30日跌1.31%,天域生物领跌,主力资金净流出1.88亿元
Zheng Xing Xing Ye Ri Bao· 2025-10-30 08:28
Core Points - The aquaculture sector experienced a decline of 1.31% on October 30, with Tianyu Biology leading the drop [1] - The Shanghai Composite Index closed at 3986.9, down 0.73%, while the Shenzhen Component Index closed at 13532.13, down 1.16% [1] Stock Performance - Yisheng Co. (002458) closed at 9.03, up 0.33% with a trading volume of 97,800 shares and a turnover of 88.43 million yuan [1] - Xiantan Co. (002746) closed at 6.31, up 0.32% with a trading volume of 154,800 shares and a turnover of 97.81 million yuan [1] - Tianyu Biology (603717) closed at 8.73, down 3.64% with a trading volume of 155,200 shares and a turnover of 137 million yuan [2] - Huaying Agriculture (002321) closed at 2.77, down 3.15% with a trading volume of 424,400 shares and a turnover of 119 million yuan [2] Capital Flow - The aquaculture sector saw a net outflow of 188 million yuan from institutional investors, while retail investors had a net inflow of 141 million yuan [2] - The main capital inflow and outflow for specific stocks included: - Jingji Zhinnong (000048) had a net inflow of 19.99 million yuan from main capital [3] - Wens Foodstuff Group (300498) had a net inflow of 7.96 million yuan from main capital [3] - Yisheng Co. (002458) had a net inflow of 3.79 million yuan from main capital [3]
猪价反弹、产能调控,猪周期新走向引关注
2 1 Shi Ji Jing Ji Bao Dao· 2025-10-30 07:49
Group 1 - The core viewpoint is that pig prices have rebounded recently, with an average price of 12.51 yuan/kg as of October 30, which is an increase of 0.18 yuan/kg from the previous day and approximately 1.5 yuan/kg higher than the lowest point in mid-October [1] - Short-term price increases are driven by seasonal consumption recovery and heightened sentiment for secondary fattening, while rising prices will increase the costs of secondary fattening, necessitating attention to the sustainability of this trend [1] - Long-term expectations indicate a downward shift in recent pig price levels, with deepening breeding losses and the advancement of capacity regulation policies, which are expected to enhance the outlook for long-term price stabilization [1] Group 2 - The Ministry of Agriculture and Rural Affairs has recently reiterated the need to strengthen the regulation of pig production capacity, with the number of breeding sows recorded at 40.35 million as of the end of September, a decrease of 450,000 from the peak at the end of last year [2] - Policy regulations regarding production capacity, slaughter weight, and environmental funding are being fully implemented, with leading companies responding positively; for instance, Muyuan Foods reported a breeding sow inventory of 3.305 million at the end of September, a reduction of 126,000 from the end of June [2] - The expectation for future market cycles indicates that capacity regulation will remain a central theme for some time, with an anticipated increase in the elimination of outdated capacity and a further emphasis on the cost advantages of high-quality production capacity, leading to better profit elasticity post-regulation [2]
农业农村部推进渔业现代化!农牧渔ETF(159275)下挫1.2%!机构:养殖业产能去化加速
Xin Lang Ji Jin· 2025-10-30 01:57
Group 1 - The agricultural and fishery ETF (159275) showed weak performance with a price drop of 1.2% and a trading volume of 1.748 million yuan, while the fund's latest scale is 205 million yuan [1] - Key stocks such as Yike Food, Meihua Biological, and Luoniushan performed well with increases of 1.01%, 0.64%, and 0.56% respectively, while Jinhe Biological, Tiankang Biological, and Weilan Biological saw declines of 4.46%, 3.59%, and 3.29% [1] - The Ministry of Agriculture and Rural Affairs emphasized the importance of solidifying key work during the 14th Five-Year Plan period to support the modernization of the fishery sector, highlighting the successful construction of the "Haiwei 2" breeding platform in Zhanjiang, Guangdong [1] Group 2 - According to data from Tianfeng Securities, the supply of yellow chickens may contract, with demand being a core variable and production capacity at its lowest since 2018, suggesting that average prices in the second half of the year may outperform the first half [2] - The pig farming sector continues to experience losses, with policy guidance aimed at reducing production leading to ongoing capacity reduction [2] - The poultry industry faces challenges due to avian influenza, with a 21.78% year-on-year decline in the number of breeding stock, but a potential recovery in industry conditions is anticipated after three years of downturn [2]
产能调控持续推进,猪价低位反弹!畜牧养殖ETF(516670)连续16日“吸金”5.2亿元
2 1 Shi Ji Jing Ji Bao Dao· 2025-10-30 01:52
Group 1 - The core viewpoint of the articles indicates a recent rebound in pig prices, with an average price of 12.51 yuan/kg as of October 30, reflecting a rise of 0.18 yuan/kg from the previous day and an increase of approximately 1.5 yuan/kg from mid-October's lowest point [1] - Short-term price increases are driven by seasonal consumption recovery and heightened sentiment for secondary fattening, while long-term trends suggest a downward shift in pig prices due to deepening breeding losses and ongoing capacity regulation policies [1] - The Ministry of Agriculture and Rural Affairs has reiterated the need for stronger regulation of pig production capacity, with the number of breeding sows recorded at 40.35 million at the end of September, a decrease of 450,000 from the peak at the end of last year [1] Group 2 - The livestock breeding ETF has attracted significant capital attention, with a net inflow of 520 million yuan over 16 consecutive days, bringing the total scale to 1.393 billion yuan, a new high since its listing [2] - The CSI Livestock Breeding Index, which covers the pig breeding industry chain, has a management fee rate of 0.2% per year, making it the lowest among ETFs tracking this index [2]
A股股票回购一览:今日26家公司披露回购进展
Xin Lang Cai Jing· 2025-10-29 23:39
Summary of Stock Buyback Activities on October 30 Core Insights - On October 30, a total of 26 companies announced 27 stock buyback-related updates, indicating a significant activity in the market [1] Group 1: New Buyback Proposals - 16 companies disclosed stock buyback proposals for the first time, with 6 companies proposing buyback amounts exceeding 10 million [1] - The highest proposed buyback amounts were from HeMai Co., Ltd. (up to 200 million), Sanli Shi (60 million), and Minsheng Health (50.544 million) [1] Group 2: Approved Buyback Plans - 2 companies had their buyback plans approved by shareholders, with the highest proposed amounts from Dayu Biological (up to 5.596 million) and New Weiling (20,200) [1] Group 3: Buyback Implementation Progress - 2 companies reported on the implementation of their buyback plans, with the highest amounts from Guyue Longshan (186 million) and Jiayi Co. (99.0246 million) [1] Group 4: Completed Buybacks - 5 companies completed buybacks exceeding 10 million, with the highest completed amounts from Huafa Co. (310 million), Shenzhou Digital (203 million), and Ruoyu Chen (200 million) [1] - As of October 30, a total of 1711 buyback plans have been completed this year, involving 1281 companies, with 330 companies completing buybacks exceeding 100 million [1] - The leading companies in completed buyback amounts include Kweichow Moutai (6 billion), Muyuan Foods (3 billion), and COSCO Shipping Holdings (2.146 billion) [1]
10月29日生物经济(970038)指数涨0.92%,成份股泰格医药(300347)领涨
Sou Hu Cai Jing· 2025-10-29 10:33
Core Insights - The Biotech Economy Index (970038) closed at 2298.38 points, up 0.92%, with a trading volume of 24.11 billion yuan and a turnover rate of 1.39% [1] - Among the index constituents, 27 stocks rose while 22 fell, with Tigermed leading the gainers at 11.09% and Kaili Medical leading the decliners at 11.39% [1] Index Performance - The Biotech Economy Index had a net inflow of 169 million yuan from institutional investors, while retail investors experienced a net outflow of approximately 79.92 million yuan [1][2] - The top ten constituents of the Biotech Economy Index include: - Mindray Medical (13.81% weight, latest price 222.83 yuan, market cap 270.17 billion yuan) [1] - Changchun High-tech (5.41% weight, latest price 117.55 yuan, market cap 47.95 billion yuan) [1] - Kanglong Chemical (4.66% weight, latest price 34.05 yuan, market cap 60.55 billion yuan) [1] - Tigermed (4.23% weight, latest price 59.48 yuan, market cap 51.21 billion yuan) [1] - Other notable constituents include Deep Technology, Muyuan Foods, and Aimeike [1] Capital Flow Analysis - The capital flow details indicate that Deep Technology had a net inflow of 201 million yuan from institutional investors, while retail investors saw a significant outflow of 222 million yuan [2] - Kanglong Chemical and Tigermed also experienced net inflows from institutional investors, but faced outflows from retail investors [2] - Overall, the data suggests a mixed sentiment among different investor classes within the Biotech Economy Index [2]